Новые подходы в комплексном лечении болезни Меньера

S.S. Arifov; M.B. Tukhtaev

doi:10.57231/j.ejohns.2023.2.1.002

New approaches in the complex treatment of Meniere's disease

Authors

S.S. Arifov Center for the Development of Professional Qualifications of Medical Workers
M.B. Tukhtaev Center for the Development of Professional Qualifications of Medical Workers

DOI:

https://doi.org/10.57231/j.ejohns.2023.2.1.002

Keywords:

Meniere's disease, conservative treatment, surgical treatment, relief of symptoms

Abstract

The aim of the study was to study new approaches in the complex treatment of Meniere's disease. The material and methods of research has compiled scientific publications on this topic, published over the past 10 years in the E-library and PubMed databases. The review showed that approaches to the diagnosis, treatment, and rehabilitation of Meniere's disease should currently be based on modern clinical guidelines formulated on the basis of the principles of evidence-based medicine.

References

Болезнь Меньера. Клинические рекомендации. Составители Крюков А.И., Кунельская Н.Л., Гаров Е.В. и др. М-СПб. 2014. 21 с.

Головокружение (периферическое). Клинические рекомендации. М. 2016. 23 с.

Зайцева О. В. Роль танакана в повышении эффективности вестибулярной реабилитации. Вестник оториноларингологии. 2014;(5):66-68.

Клаудио Борги, Антонио Пи Омега-3 жирные кислоты: многообещающее возможное лечение болезни Меньера и других заболеваний внутреннего уха неизвестного происхождения?

Крюков А.И., Антонян Р.Г., Гаров Е.В., Шеремет А.С. Лазерная хирургия внутреннего уха. М.: Мир Урании, 2009

Кунельская Н.Л., Гусева А.Л., Чистов С.Д. Уровень b-эндорфина, хронический стресс и депрессия при вестибулярной патологии. Вестн. оториноларингологии. 2015; 1: 12–16.

Лиленко А.С. Сравнение отдаленных результатов дренирования эндолимфатического мешка с его шунтированием и без пациентов с болезнью Меньера. Рос. оториноларингология. 2014; 1: 140–43.

Митеш Патель, Киран Агарвал, Кадир Аршад, Мохамед Харири, Питер Ри, Барри М. Зеемунгал, Джон Ф. Голдинг, Джонни П Харкорт, Адольфо М. Бронштейн. Интратимпанический метилпреднизолон в сравнении с гентамицином у пациентов с односторонней болезнью Меньера: рандомизированное, двойное слепое, сравнительное исследование эффективности Ланцет 2016; 388: 2753–62.

Оториноларингология. Национальное руководство. / под ред. В. Т. Пальчуна. - М. : ГЭОТАР-Медиа, 2020. - 1060 с. - ISBN: 978-5-9704-3746-9.

Пальчун В.Т., Гусева А.Л., Левина Ю.В. Болезнь Меньера: эпидемиология, патогенез, диагностика, лечение. Consilium Medicum. 2016; 18 (3): 107–116.

Пальчун В. Т., Левина Ю. В. Рассечение эндолимфатического протока при болезни Меньера// Вестник оториноларингологии. 2003;3:70-77.

Папина Н.А. Современные аспекты хирургического лечения болезни Меньера.Вестн. оториноларингологии. 2000; 4: 67–70

Ярославская М.А., Петровская А.Н. Психологические особенности пациентов с болезнью Меньера и их психосоциальная адаптация. Вестн. оториноларингологии. 2013; 6: 99–101.

Alfonso Scarpa, Massimo Ralli, Claudia Cassandro, Federico Maria Gioacchini, Matteo Alicandri-Chufelli, Pasquale Viola, Giuseppe Chiarella, Marco de Vincentis, Ettore Cassandre Intrasympanic administration of low doses of gentamicin for unilateral clinical results using Meniere's disease ... Am J Otolaryngol 40 (2019) 102289.

Antonio SM, Friedman R. Meniere’s Disease. In: R.K.Jackler, D.E.Brackmann, eds. Neurotology. Philadelphia: Elsevier, 2005; p. 621–38.

Bel Büki, Heinz Jüngerel Intratympanal Gentamicin in Menyer 'Disease: Human Effects Semicircular Auris Nasus Larynx 45 (2018) 39 - 44.

Bolignano D, Coppolino G, Criseo M et al. Aquaretic agents: what’s beyond the treatment of hyponatremia? Curr Pharm Des 2007; 13: 865–871.

Brandt T, Dieterich M, Strupp M. Vertigo and dizziness – common complaints. 2. London: Springer; 2013. 208 p. DOI 10.1007/978-0-85729-591-0

Bronstein A. Oxford Textbook of Vertigo and Imbalance. Barcelona: Oxford University Press, 2013. 368 p. DOI: 10.1093/med/9780199608997.001.0001

Coelho DH, Lalwani AK. Medical management of Mȅniȅre's disease. Laryngoscope. 2008; 118 (6): 1099–108. Doi: 10.1097/MLG.0b013e31816927f0.

Crane BT, Minor Lloyd B. Cummings Otolaryngology, 5th edition. 2010; 2548-256.

da Costa SS. Central causes of vertigo. In: Souza SD, Claussen C, ed. Modern concepts of neurology. Mumbai: Prajakta Arts, 1997: 310–31.

Daniel S. Roberts, William H. Slattery, Meniere's Labyrintectomy 'Disease. Operational techniques in otolaryngology (2016) 27, 188 – 193

Eisenberg DM, Davis RB, Ettner SL et al. Trends in alternative medicine use in the United States, 1990–1997: results of a follow-up national survey. JAMA 1998; 280: 1569–75

Foster CA. Optimal management of Mȅniȅre's disease. Ther Clin Risk Manag 2015;11: 301–7. Doi: 10.2147/TCRM.S59023.

Gates GA, Green JD Jr, Tucci DL, Telian SA. The effects of transtympanic micropressure treatment in people with unilateral Ménière’s disease. Arch Otolaryngol Head Neck Surg 2004; 130 (6): 718–25.

Hamed Sajjadi, Michael M. Paparella. Lancet 2008; 372: 406-14. Lavigne P, Lavigne F, Saliba I. Intratympanic corticosteroids injections: a systematic review of literature. Eur Arch Otorhinolaryngol 2015. Doi: 10.1007 / s00405-015-3689-3.

Hetal H. Patel, MD, Huseyin Isildak, MD Mmener 'Disease Review Operative Techniques in Otolaryngology (2016) 27, 184 - 187.

Jenny IKS. Chen, Zizi Yu, Steven D. Раух находящийся в барабанной полости гентамицин инъекция для Меньера болезньля Меньера болезнь Оперативный Техники в Отоларингология 30 (2019) 180–186.

Kayhan Ozturk, Nurdo g Ata Intratipan mixture of gentamicin and dexamethasone in comparison with dexamethasone in unilateral Meniere's disease Am J Otolaryngol 40 (2019) 711-714.

Lauren J. Bartels, Christopher J. Danner, Boren J. Kyle P. Allen from Phi based on Meniere 'Disease Management Operative Techniques in Otolaryngology (2016) 27, 225 – 234

Lavigne P, Lavigne F, Saliba I. Intratympanic corticosteroids injections: a systematic review of literature. Eur Arch Otorhinolaryngol 2015. Doi: 10.1007/s00405-015-3689-3.

Lezius F, Adrion C, Mansmann U et al. High-dosage betahistine dihydrochloride between 288 and 480 mg / day in patients with severe MeniПre's disease: a case series. Eur Arch Otorhinolaryngol 2011; 268 (8): 1237-40. Doi: 10.1007 / s00405-011-1647-2.

Li CS, Lai JT. Evaluation of retrosigmoid vestibular neurectomy for intractable vertigo in Meniere’s disease: an interdisciplinary review. Acta Neurochir (Wien) 2008; 150 (7): 655–61; discussion 661. Doi: 10.1007/s00701-007-1462-0.

Locke RR, Shaw-Dunn J, O'Reilly BF. Endolymphatic sac surgical anatomy and transmastoid decompression of the sac for the management of Mйniиre's disease. J Laryngol Otol 2014; 128 (6): 488–93. Doi: 10.1017/S0022215114001017.

Lopez-Escamez JA, Carey J, Chung WH, et al: Diagnostic criteria for Meniere's disease. J Vestib Res: 1-7, http://dx.doi.org/10.3233/VES150549 2015 Vestib Res: 1-7

MeyerhoﬀWL, Paparella MM, Meniere's disease and children. Laryngoscope 1978; 88: 1504-11.

Miyashita TM T, et al: Hormonal changes after a low-salt diet in patients with Meniere's disease Auris Nasus Larynx, 2016

Morales-Luckie E, Cornejo-Suarez A, Zaragoza-Contreras MA, Gonzalez-Perez O. Oral administration of prednisone to control refractory vertigo in Mȅniȅre’s disease: a pilot study. Otol Neurotol 2005; 26 (5): 1022–6.

Morse GG, House JW. Changes in Mйniиre’s disease responses as a function of the menstrual cycle. Nurs Res 2001; 50: 286–292

Orji F. The Influence of Psychological Factors in Meniere's Disease.Ann Med Health Sci Res. 2014; 4 (1): 3–7. Doi: 10.4103/2141-9248.126601

Phillips JS, Westerberg B. Intratympanic steroids for Ménière’s disease or syndrome // Cochrane Database Syst Rev. 2011; 7: CD008514.

Postema RJ, Kingma CM, Wit HP et al. Intratympanic gentamicin therapy for control of vertigo in unilateral Menire's disease: a prospective, double-blind, randomized, placebocontrolled trial. Acta Otolaryngol 2008; 128: 876-80.

Pullens B, van Benthem PP. Intratympanic gentamicin for Ménière’s disease or syndrome // Cochrane Database Syst Rev. 2011; 3: CD008234.

Ramos Alcocer R, Ledezma Rodrнguez JG et al. Use of betahistine in the treatment of peripheral vertigo. Acta Otolaryngol 2015; 135 (12): 1205–11. Doi:10.3109/00016489.2015.1072873.

SeyedTootoonchi SJ, Ghiasi S, Shadara P et al. Hearing function after betahistine therapy in patients with Meniere's disease. Braz J Otorhinolaryngol 2015; pii: S1808-8694(15)00234-7. Doi: 10.1016/j.bjorl.2015.08.021

Silviu Albu, MD, PhD, Alina Nadia, Caius Doros, Luigi Marcianu, Sebastian Cozma, Gabriela Musat, Franco Trabalzini Meniere's Disease with Dimamethasone Plus High Dose Betahistina AMERICAN JOURNAL OF OPHOTOLOGYA 6 2 2 5 – 2

Simon L. Greenberg, Julian M. Nedzelsky Medical and Non-Destructive Therapy for M enier D eisese Otolaryngol Clin N Am 43 (2010) 1081-1090 doi: 10.1016 / j.otc. 2010.05.005.

Söderman AC, Möller J, Bagger-Sjöbӓck D et al. Stress as a trigger of attacks in Meniere’s disease. A case-crossover study. Laryngoscope 2004; p. 1843–48.

Tadashi Kitahara Evidence that surgical treatment for intractable Meniere's disease Auris Nasus Larynx 45 (2018) 393 – 398

Thirlwall AS, Kundu S. Diuretics for Mȅniȅre's disease or syndrome. Cochrane Database Syst Rev. 2006; 3: CD003599

Van Cruijsen N, Dullaart RP, Wit HP, Albers FW. Analysis of cortisol and other stressrelated hormones in patients with Mйniиre’s disease. Otol Neurotol 2005; 26: 1214–19

Van de Heyning PH, Verlooy J, Schatteman I, Wuyts FL. Selective vestibular neurectomy in Menière’s disease: a review // Acta Otolaryngol Suppl. 1997; 526: 58–66.

Zhang SL, Leng Y, Liu B et al. Meniett Therapy for Ménière’s Disease: An Updated Meta-analysis. Otol Neurotol 2016.

Zingler VC, Cnyrim C, Jahn K et al. Causative factors and epidemiology of bilateral vestibulopathy in 255 patients. Ann Neurol 2007; 61 (6): 524–32.